Abstract:
According to the invention there is provided a strain of lactic acid bacteria of the genus Lactobacilli obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Lactobacilli of the present invention are also provided.
Abstract:
A Bifidobacterium strain, AH208, AH209, AH2I0, AH2ll, AH212 or AH214 or mutants or variants thereof are useful in the prophylaxis and/or treatment of inflammatory activity especially undesirable gastrointestinal inflammatory activity, such as inflammatory bowel disease or irritable bowel syndrome.
Abstract:
The present invention relates to a method for screening bacteria which are beneficial to human health, and to specific strains selected using the method. In specific, the invention provides a method for screening probiotic strains of bifidobacteria, which can be used in production of cereal-based functional and clinical food products or dietary supplements.
Abstract:
Silage is treated with a novel formulation of bacteria that, in combination, are capable of producing lactic, acetic and propionic acids on fermentation. Improved aerobic stability is achieved, by providing a suitable acid profile.
Abstract:
Improved meals, improved meal compositions, and improved aquaculture feed compositions are provided based on plant meal, wherein anti-nutritional effects of one or more anti-nutritional substances (ANS) are mitigated. Also provided are methods for making and using the improved meals, improved meal compositions, and improved aquaculture feed compositions. Also provided are kits using the improved meals, improved meal compositions, and improved aquaculture feed composition. The improved meals, improved meal compositions, and improved aquaculture feed compositions demonstrate that plant meal protein digestibility may be improved, for example, for replacing fish meal protein.
Abstract:
The present invention provides for systems, compositions, methods and kits for regulating energy metabolism in pets. The systems, compositions, and kits can comprise, and methods can make use of, pet foods, pet treats, pet supplements, and pet drinks. In one aspect, the invention provides for pet food, treat, supplement, and drink compositions that comprise a combination of (a) leucine, and (b) vitamin B6, or any precursors or metabolites of (a) or (b). These combinations may be effective for reducing weight or adipose volume in the pet. In another aspect, the invention provides for methods of regulating energy metabolism by the administration of one or more compositions comprising leucine, a leucine metabolite, and/or vitamin B6. The invention also provides for kits comprising compositions of leucine, a leucine metabolite, and/or vitamin B6 packaged in an oral dose form with usage instructions.
Abstract:
본 발명은 새우사료 첨가제 조성물 및 그 제조방법에 관한 것으로, 더욱 상세하게는 양식새우의 생존율 및 성장률을 높이고 해수오염을 방지하기 위한 새우사료 첨가제 조성물 및 그 제조방법에 관한 것이다. 본 발명은 미생물인 효모균, 바실러스 서브틸러스(bacillus subtilis, 고초균), 유산균과 천연물질인 홍삼, 다시마, 우뭇가사리, 함초, 방풍, 파래, 민들레, 백출, 미나리, 갈근 등과 사과, 오렌지, 귤, 파인애플, 멜론 등의 과일을 발효시킨 것을 혼합하고 효소액을 추출하여 항바이러스, 면역력 증강, 소화력 증강, 성장촉진, 잔류사료 분해 등의 효과를 거둘 수 있는 새우사료 첨가제의 제조방법을 개시한다.
Abstract:
Use of a mixture live cultures probiotic bacteria in a mixture with short chained fatty acids (SCFA), in a slow release form for the active ingredients, of various release structures and mechanisms, in particular in the form of a triglyceride matrix; in the diet of monogastric animals, in particular a human diet, for modulating intestinal bacterial flora as well as improving the acid-base and water-electrolyte balance of the gastrointestinal tract; in the manufacturing of a preparation for maintaining bacterial and acid-base homeostasis of the distal portion of the gastrointestinal tract of monogastric animals, including the human small intestine and colon.
Abstract:
The present invention relates generally to the field of cosmetic and/or food supplement. More specifically, the present invention aims to provide the use of at least an ingredient containing caftaric acid and/or derivatives and a micro-organism and/or an enzyme capable of hydrolyzing caftaric acid and/or derivatives thereof to generate tartaric and/or caffeic acid, for improving skin tone and preventing and/or treating hyper-pigmentation of skin and/or skin color imperfections such as age-spots and other skin disorders characterized by abnormal pigments. Also, the present invention aims at providing a skin lightening agent.